Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells

The breakthrough of induced pluripotent stem cell (iPSC) technology has raised the possibility that patient-specific iPSCs may become a renewable source of autologous cells for cell therapy without the concern of immune rejection. However, the immunogenicity of autologous human iPSC (hiPSC)-derived...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cell stem cell 2015-09, Vol.17 (3), p.353-359
Hauptverfasser:	Zhao, Tongbiao, Zhang, Zhen-ning, Westenskow, Peter D., Todorova, Dilyana, Hu, Zheng, Lin, Tongxiang, Rong, Zhili, Kim, Jinchul, He, Jingjin, Wang, Meiyan, Clegg, Dennis O., Yang, Yong-guang, Zhang, Kun, Friedlander, Martin, Xu, Yang
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antigens - metabolism Cell Differentiation Humans Immunity Induced Pluripotent Stem Cells - cytology Induced Pluripotent Stem Cells - immunology Mice Myocytes, Smooth Muscle - immunology Retinal Pigment Epithelium - immunology T-Lymphocytes - immunology Teratoma - pathology Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!